Literature DB >> 16180229

Tumor budding and evidence-based treatment of T2 rectal carcinomas.

Tadahiko Masaki1, Hiroyoshi Matsuoka, Masanori Sugiyama, Nobutsugu Abe, Atsuhiko Sakamoto, Toshiaki Watanabe, Hirokazu Nagawa, Yutaka Atomi.   

Abstract

BACKGROUND: The validity of the histological criteria in deciding additional bowel resection after local excision of T2 rectal carcinomas is questioned.
METHODOLOGY: In 72 T2 colorectal carcinomas resected by major surgery, the associations between lymph node metastasis (LNM) and clinicopathologic parameters were examined statistically, a prediction formula for LNM was constructed and decision analysis was attempted.
RESULTS: Multivariate analysis showed that female gender and a greater number of tumor budding were significantly associated with LNM. The probability of LNM can be calculated as follows; Z = 0.037 x (budding number) + 2.08 x (SEX; male, 1; female, 2) - 5.736; Probability = 1/1 + e(-Z). When a 75-year-old patient has pulmonary complications, the operative risk is assumed to be over 2%. If a number of tumor budding is 0, the risk of LNM is calculated as 2.4% in a male and 17.1% in a female patient. On the assumption that the risk of liver metastasis is half of that of LNM, and the salvageabilities after LNM and liver metastasis are 20% and 50%, respectively, observation policy is justified for a male patient, whereas additional surgery should be undertaken for a female patient.
CONCLUSIONS: A number of tumor budding may be useful for determining the individualized treatment of T2 rectal carcinomas.

Entities:  

Mesh:

Year:  2005        PMID: 16180229     DOI: 10.1002/jso.20369

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

Review 1.  Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.

Authors:  F Petrelli; E Pezzica; M Cabiddu; A Coinu; K Borgonovo; M Ghilardi; V Lonati; D Corti; S Barni
Journal:  J Gastrointest Cancer       Date:  2015-09

2.  Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.

Authors:  Inti Zlobec; Francesca Molinari; Vittoria Martin; Luca Mazzucchelli; Piercarlo Saletti; Rosangela Trezzi; Sara De Dosso; Tatjana Vlajnic; Milo Frattini; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

Review 3.  Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases.

Authors:  Sean C Glasgow; Joshua I S Bleier; Lawrence J Burgart; Charles O Finne; Ann C Lowry
Journal:  J Gastrointest Surg       Date:  2012-01-19       Impact factor: 3.452

4.  Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

5.  Evaluation of risk factors for lymph node metastasis in T2 lower rectal cancer to perform chemoradiotherapy after local resection.

Authors:  Hajime Ushigome; Masayuki Ohue; Masaki Kitamura; Shinichi Nakatsuka; Naoaki Haraguchi; Junichi Nishimura; Masayoshi Yasui; Hiroshi Wada; Hidenori Takahashi; Takeshi Omori; Hiroshi Miyata; Masahiko Yano; Shuji Takiguchi
Journal:  Mol Clin Oncol       Date:  2020-02-03

Review 6.  Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.

Authors:  Inti Zlobec; Alessandro Lugli
Journal:  Oncotarget       Date:  2010-11

7.  Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.

Authors:  Michael S Landau; Steven M Hastings; Tyler J Foxwell; James D Luketich; Katie S Nason; Jon M Davison
Journal:  Mod Pathol       Date:  2014-04-25       Impact factor: 7.842

Review 8.  Tumour budding in rectal cancer. A comprehensive review.

Authors:  Leonardo S Lino-Silva; Rosa A Salcedo-Hernández; Armando Gamboa-Domínguez
Journal:  Contemp Oncol (Pozn)       Date:  2018-06-30

Review 9.  Tumor budding in upper gastrointestinal carcinomas.

Authors:  Viktor H Koelzer; Rupert Langer; Inti Zlobec; Alessandro Lugli
Journal:  Front Oncol       Date:  2014-08-14       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.